ABT - NEW YORK STOCK EXCHANGE, INC.
Industry: Health Care
Market Cap: 231.8 B
IPO Date: Mar 1, 1937
Country: US
Currency: USD
Shares Outstanding: 1.7 B
5/10/2025
See here for weekly updates on Dividend Champions, Contenders & Challengers. Find dividend changes, ex-dividend dates & payment schedules.
Source: SeekingAlpha
5/9/2025
NVIDIA, Abbott Laboratories, Linde and Tredegar are part of the Zacks top Analyst Blog
Source: Yahoo
5/9/2025
We recently published a list of 11 Best Medical Device Stocks to Buy Now. In this article, we are going to take a look at where Abbott Laboratories (NYSE:ABT) stands against other best medical device stocks to buy now. Trump’s Tariffs Are Dividing the Medical Community On April 16, CNBC reported that Trump’s tariffs are […]
Source: Yahoo
5/8/2025
Today's Research Daily features new research reports on 16 major stocks, including NVIDIA Corp. (NVDA), Abbott Laboratories (ABT) and Linde plc (LIN), as well as a micro-cap stock Tredegar Corp. (TG).
Source: Yahoo
5/8/2025
ABBOTT PARK - Abbott announced the creation of the inaugural 'Abbott Dream Team.'The program will seek out talented soccer players from across the United States and give them a once-in-a-lifetime...
Source: Finnhub
5/8/2025
As the Q1 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the medical devices & supplies - diversified industry, including Abbott Laboratories (NYSE:ABT) and its peers.
Source: Yahoo
5/7/2025
Despite trade policy challenges, Abbott's global footprint and 90 manufacturing sites offer flexibility to manage regional risks and reroute supply chains.
Source: Yahoo
5/7/2025
Mairs & Power, an investment advisor, released the “Mairs & Power Balanced Fund” first quarter 2025 investor letter. A copy of the letter can be downloaded here. The stock market reached a record high in February. However, tariff uncertainty in March led to a fall in equities, while fixed income benefited from perceived safety. The […]
Source: Yahoo
5/7/2025
Abbott (ABT) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Source: Yahoo
5/7/2025
We recently published a list of Jim Cramer Talked About These 7 Stocks Recently. In this article, we are going to take a look at where Abbott Laboratories (NYSE:ABT) stands against other stocks that Jim Cramer discussed recently. On Monday, Jim Cramer, host of Mad Money, shared valuable insights from his years of experience as […]
Source: Yahoo
5/7/2025
2024 also saw some changes to some of my holdings as the author shuttled several dividend income payers for higher return crypto plays. Click to read.
Source: SeekingAlpha
5/7/2025
Abbott Laboratories ( NYSE:ABT ) announced strong profits, but the stock was stagnant. We did some digging, and we...
Source: Yahoo
5/7/2025
For Q1 2025, the Fidelity Select Health Care Portfolio returned -1.03%, underperforming the MSCI health care index. Click here to read the full commentary.
Source: SeekingAlpha
5/7/2025
Wrapping up Q1 earnings, we look at the numbers and key takeaways for the medical devices & supplies - diversified stocks, including Neogen (NASDAQ:NEOG) and its peers.
Source: Yahoo
5/6/2025
Though designed as economic tools, tariffs have ripple effects that extend into the regulatory framework of the medical device sector.
Source: Yahoo
5/6/2025
Smart Beta ETF report for VALQ
Source: Yahoo
5/6/2025
For Q1 2025, Fidelity Value Discovery Fund gained 2.16%, outpacing the 1.64% advance of the benchmark Russell 3000® Value Index. Click here to read the full commentary.
Source: SeekingAlpha
5/6/2025
"Too big to fail" is how we would describe the megacap stocks in this article today. While they will likely stand the test of time, it’s not all sunshine and rainbows as their scale can limit their ability to find new sources of growth.
Source: Yahoo
5/6/2025
Wrapping up Q1 earnings, we look at the numbers and key takeaways for the medical devices & supplies - diversified stocks, including Stryker (NYSE:SYK) and its peers.
Source: Yahoo
5/3/2025
Abbott Laboratories ( NYSE:ABT ) First Quarter 2025 Results Key Financial Results Revenue: US$10.4b (up 4.0% from 1Q...
Source: Yahoo